Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Bowel (colorectal) cancer, Colon cancer, Rectal cancer
Closed
Phase 2
This trial is looking at 2 drugs called capecitabine and aflibercept for people who have bowel cancer that has spread elsewhere in the body.
Recruitment start: 31 March 2014
Recruitment end: 31 December 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Paul Ross
Experimental Cancer Medicine Centre (ECMC)
Guy's and St Thomas' NHS Foundation Trust
Sanofi Aventis
Last reviewed: 02 Jan 2019
CRUK internal database number: 11777